Quantitation of HERV-K env gene expression and splicing in human breast cancer.
about
Human endogenous retroviruses: transposable elements with potential?'There and back again': revisiting the pathophysiological roles of human endogenous retroviruses in the post-genomic eraComprehensive analysis of human endogenous retrovirus transcriptional activity in human tissues with a retrovirus-specific microarrayNp9 protein of human endogenous retrovirus K interacts with ligand of numb protein XL1 and HERV-W retrotransposons are hypomethylated in human ovarian carcinomasMultiplex degenerate PCR coupled with an oligo sorbent array for human endogenous retrovirus expression profilingHuman endogenous retrovirus K and cancer: Innocent bystander or tumorigenic accomplice?Endogenous retroviruses as targets for antitumor immunity in renal cell cancer and other tumorsGenetic Engineering of T Cells to Target HERV-K, an Ancient Retrovirus on MelanomaViruses and human breast cancerTherapeutic potential of antiviral drugs targeting chemorefractory colorectal adenocarcinoma cells overexpressing endogenous retroviral elementsVariable transcriptional activity of endogenous retroviruses in human breast cancerReactivation of codogenic endogenous retroviral (ERV) envelope genes in human endometrial carcinoma and prestages: Emergence of new molecular targets"Reverse genomics" and human endogenous retroviruses.Custom human endogenous retroviruses dedicated microarray identifies self-induced HERV-W family elements reactivated in testicular cancer upon methylation control.Human endogenous retrovirus W activity in cartilage of osteoarthritis patients.Biogenesis of extracellular vesicles (EV): exosomes, microvesicles, retrovirus-like vesicles, and apoptotic bodies.Elevated HERV-K mRNA expression in PBMC is associated with a prostate cancer diagnosis particularly in older men and smokersThe distribution of insertionally polymorphic endogenous retroviruses in breast cancer patients and cancer-free controls.Human endogenous retrovirus type K antibodies and mRNA as serum biomarkers of early-stage breast cancer.HERV-K(HML-2), a seemingly silent subtenant - but still waters run deep.Human endogenous retroviruses and cancer prevention: evidence and prospectsIdentification and detection of a novel human endogenous retrovirus-related gene, and structural characterization of its related elements.Implication of human endogenous retrovirus envelope proteins in placental functions.Vaccination directed against the human endogenous retrovirus-K envelope protein inhibits tumor growth in a murine model system.Sensitive detection of viral transcripts in human tumor transcriptomes.Tropism, cytotoxicity, and inflammatory properties of two envelope genes of murine leukemia virus type-endogenous retroviruses of C57BL/6J miceDifferential expression of HERV-K (HML-2) proviruses in cells and virions of the teratocarcinoma cell line Tera-1.Identification, characterization, and comparative genomic distribution of the HERV-K (HML-2) group of human endogenous retroviruses.Immunotherapeutic potential of anti-human endogenous retrovirus-K envelope protein antibodies in targeting breast tumorsExpression of Human Endogenous Retrovirus Type K Envelope Protein is a Novel Candidate Prognostic Marker for Human Breast Cancer.Extracellular vesicles and their synthetic analogues in aging and age-associated brain diseases.Chimeric antigen receptor T cells targeting HERV-K inhibit breast cancer and its metastasis through downregulation of RasEndogenous retroviruses and animal reproduction.Human RNA "rumor" viruses: the search for novel human retroviruses in chronic diseaseHuman endogenous retrovirus (HERV-K) reverse transcriptase as a breast cancer prognostic marker.Endogenous retrovirus-K promoter: a landing strip for inflammatory transcription factors?Human endogenous retrovirus K (HML-2) elements in the plasma of people with lymphoma and breast cancer.Detection of an Immunogenic HERV-E Envelope with Selective Expression in Clear Cell Kidney Cancer.HERV-K(HML-2), the Best Preserved Family of HERVs: Endogenization, Expression, and Implications in Health and Disease.
P2860
Q22065700-837AA992-2329-414A-824A-5E1CCF54CE7CQ24289157-F85BFEAC-DD33-47EF-95DB-049E287DE208Q24558698-EA643ABC-EDBE-4F45-9F73-AF13D2E6DA1DQ24562056-EF9019F0-2377-439F-A458-5683749291D0Q24799489-19A830CC-023E-4290-803F-BBEA824C9E47Q25257310-CADA37B9-B287-4142-99FD-D1B48E63B2C4Q27010373-87752260-5BAB-4BC5-A661-573B449510F7Q27026023-A5C92B0F-353F-4D11-BCC8-7BEDF272904CQ27346600-A263C304-1DFA-4EDF-AC79-238C77729423Q28238361-FF88382E-C7BE-4F22-990D-1186A45AA384Q28610460-AAD47F9D-8D09-4219-AD80-24D1303C1A8DQ28755451-533A6EA9-35C0-4F5B-A62D-3217F33F4E3EQ30418097-13B26E73-1DB9-4120-8C0C-9C361CE699F3Q30842942-F49684E2-DB87-43AE-A82F-F09B094E87CCQ33783200-320F083F-7EB5-48C4-88BB-CFD9B80ED674Q34033196-5880858F-7B00-4249-8110-0E592C1F80D0Q34035888-36BC2AFB-D7F1-4E4E-AC7E-F5E4FC381813Q34096832-3ED889A5-D804-4F8F-961A-0637FC5C384FQ34109274-CA384EE7-C25D-4DC8-96B8-96BC3297719BQ34315003-F67EF00E-D4C9-45CB-9ECD-444AC5393A1BQ34511101-975B19D3-9F9C-4A5D-AA26-297D686575C5Q34530623-B8FE1E11-7088-43A6-A7FA-E621780A4881Q34565464-7C260048-B074-4CDA-AF7C-3C9F51BD57EEQ34580891-38439204-ED32-4BA5-B524-8844FAD2C459Q34983603-7009847D-D675-45FC-BD2B-204C1D42E777Q35008736-A304C653-5331-4D62-A816-4D36DA2260BBQ35099223-94647D91-A8B9-44D2-81AD-195DDDF7CF1DQ35232788-C6A7B9F9-D70C-4CD1-A383-E82E5F61470FQ35586619-4655FDC9-66D1-402E-893B-E382138BB088Q35742389-0DE05A5A-389E-47E1-AECE-1CEE0B6908B3Q35959733-8CC78994-0A1F-4BE1-94D9-5421511EBBCFQ36081720-9A155EBF-A320-4603-AE0F-F4D1BD8C79A2Q36110284-F914F1AE-9FF2-4EA4-8D22-E4ABBAD5FE99Q36225336-2CB5D892-EB6E-42E5-9556-A60F40C289DEQ36497719-2A63B229-03B3-428B-A180-7E5CEE9D38E6Q36661707-23F1538D-9720-4E0A-942F-E6C6C9E9ACF3Q36687211-81B76A45-FE46-4F68-9CBE-4CAAB457793DQ36898870-F2908198-E863-445B-B69E-2078DBBE1FF4Q36918135-BE37ADCD-8961-4F3D-BD35-990F532271F3Q37186225-199F4F48-90B6-4381-9D43-1C7FFAB57DD1
P2860
Quantitation of HERV-K env gene expression and splicing in human breast cancer.
description
2003 nî lūn-bûn
@nan
2003 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մարտին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Quantitation of HERV-K env gene expression and splicing in human breast cancer.
@ast
Quantitation of HERV-K env gene expression and splicing in human breast cancer.
@en
Quantitation of HERV-K env gene expression and splicing in human breast cancer.
@nl
type
label
Quantitation of HERV-K env gene expression and splicing in human breast cancer.
@ast
Quantitation of HERV-K env gene expression and splicing in human breast cancer.
@en
Quantitation of HERV-K env gene expression and splicing in human breast cancer.
@nl
prefLabel
Quantitation of HERV-K env gene expression and splicing in human breast cancer.
@ast
Quantitation of HERV-K env gene expression and splicing in human breast cancer.
@en
Quantitation of HERV-K env gene expression and splicing in human breast cancer.
@nl
P2093
P2860
P356
P1433
P1476
Quantitation of HERV-K env gene expression and splicing in human breast cancer.
@en
P2093
Andra R Frost
Danielle W Lu
Feng Wang-Johanning
Gary L Johanning
P2860
P2888
P304
P356
10.1038/SJ.ONC.1206241
P407
P577
2003-03-01T00:00:00Z
P5875
P6179
1039282600